Clinical Trials
Closed
Phase
Accrual
18%
Published
SWOG Clinical Trial Number
SWOG-9118
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9060
A Pilot Study Evaluation of Multimodality Treatment of Local Regional Esophageal Carcinoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
11-01-1991
Closed
03-01-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
Trial of Adjuvant Chemoradiation After Gastric Resection For Adenocarcinoma, Phase III
Research Committee(s)
Gastrointestinal Cancer
Activated
08-01-1991
Closed
07-15-1998
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9045
Evaluation of Quality of Life in Patients with Advanced Colorectal Cancer Enrolled on SWOG-8905
Activated
03-01-1991
Closed
01-15-1993
Closed
Phase
Accrual
67%
Published
SWOG Clinical Trial Number
SWOG-9000
Biomarkers of Colorectal Cancer Prognosis
Research Committee(s)
Gastrointestinal Cancer
Activated
02-15-1991
Closed
09-15-1993
Closed
Phase
Accrual
95%
Published
SWOG Clinical Trial Number
SWOG-9009
Pilot Study for Analysis of Lymphocyte Subsets and Natural Killer Activity after Treatment with Levamisole
Research Committee(s)
Gastrointestinal Cancer
Activated
12-15-1990
Closed
08-07-1992
Closed
Phase
Accrual
46%
Published
SWOG Clinical Trial Number
SWOG-8730
Evaluation of Amonafide in Esophageal Cancer
Activated
11-01-1990
Closed
04-15-1992
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-8936
Evaluation of Piroxantrone in Gastric Carcinoma
Activated
11-01-1990
Closed
06-15-1992
Closed
Phase
Accrual
77%
Published
SWOG Clinical Trial Number
SWOG-9006
A Phase II 19F Magnetic Resonance Spectroscopy (MRS) Study of 5-FU and Correlation with Clinical Results of 5-FU/Leucovorin (LV) Therapy in Patients with Carcinomas of the Gastrointestinal Tract
Research Committee(s)
Gastrointestinal Cancer
Activated
10-15-1990
Closed
11-01-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8933
Evaluation of Piroxantrone in Pancreatic Adenocarcinoma
Activated
09-01-1990
Closed
09-15-1991
Closed
Phase
Accrual
5%
SWOG Clinical Trial Number
SWOG-8901
Closed
Phase
Accrual
23%
SWOG Clinical Trial Number
SWOG-8939
Evaluation of Merbarone in Colorectal Cancer
Activated
04-15-1990
Closed
07-15-1991
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-8916
Evaluation of Merbarone in Pancreatic Adenocarcinoma
Activated
03-15-1990
Closed
06-15-1991
Closed
Phase
Accrual
63%
Published
SWOG Clinical Trial Number
SWOG-8906
Evaluation of Merbarone in Hepatoma, Phase II
Activated
02-01-1990
Closed
05-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8910
Evaluation of Low Dose Continuous 5-Fluorouracil (5-FU) and Weekly Cis-Platinum (CDDP) in Advanced Adenocarcinoma of the Stomach
Activated
01-15-1990
Closed
08-01-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8917
5-Fluorouracil, Leucovorin and Roferon-A® in Advanced Colorectal Cancer, Phase II Pilot
Activated
12-01-1989
Closed
02-15-1992
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8905
Phase II/III Study of Fluorouracil (5-FU) and its Modulation in Advanced Colorectal Cancer
Activated
08-01-1989
Closed
01-01-1993
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-8832
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Pancreatic Cancer
Activated
04-01-1989
Closed
11-15-1990
Closed
Phase
Accrual
14%
SWOG Clinical Trial Number
SWOG-8823
Phase II Study of Continuous Infusion Recombinant Interleukin-2 (r-IL2) in Patients with Colorectal Carcinoma
Activated
04-01-1989
Closed
11-15-1990
Closed
Phase
Accrual
17%
SWOG Clinical Trial Number
SWOG-8820
Fluorouracil/Leucovorin and Embolization in the Treatment of Duke's D Colon Cancer, Phase II Pilot
Activated
03-01-1989
Closed
06-15-1991